Biography

Naomi Aronson

Executive Director

Clinical Evaluation

Innovation and Policy

Blue Cross Blue Shield Association

Dr. Naomi Aronson leads BCBSA clinical effectiveness and policy engagement with government, regulatory agencies and policy consortia. Her areas of leadership include comparative effectiveness, patient centered research, safety surveillance, regulatory science and methodological standards. Previously, Dr. Aronson led the development of the BCBSA Technology Evaluation Center (TEC), now Evidence Streetâ„¢ (ES), as a nationally recognized technology assessment program and an Evidence- based Practice Center (EPC) of the Agency for Healthcare Research and Quality (AHRQ).

She is a member of the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI), the Health Technology Assessment International Health Policy Forum, the National Academy of Medicine Genomics Roundtable, the New Drug Development Paradigms (NEWDIGS) initiative of the MIT Center for Biomedical Innovation, and the Medical Device Innovation Consortium (MDIC) National Evaluation System for Health Technology (NEST) Governing Committee.

Prior to joining BCBSA, Dr. Aronson was a member of the Northwestern University faculty, specializing in the sociology of science and medicine. She also was a post-doctoral fellow in the Science, Technology and Society Program at the Massachusetts Institute of Technology.